Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-037743
Filing Date
2015-06-17
Accepted
2015-06-17 18:51:05
Documents
2
Period of Report
2015-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v413292_3.html 3  
1 OWNERSHIP DOCUMENT v413292_3.xml 3 1510
2 EXHIBIT 24 v413292_ex24.htm EX-24 7760
  Complete submission text file 0001144204-15-037743.txt   10707
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 390 LEXINGTON MA 02421
Business Address
Maki David (Reporting) CIK: 0001644981 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36199 | Film No.: 15938218